<DOC>
	<DOCNO>NCT00616486</DOCNO>
	<brief_summary>Low frequency ( 1Hz ) rTMS apply bilaterally simultaneously SMA 6 week addition standard treatment regimen OCD , lead significant improvement patient ' symptom . The clinical improvement detect YBOCS , CGI SF-36 QOLS score statistically significant active treatment group compare sham ( placebo ) treatment group .</brief_summary>
	<brief_title>rTMS Treatment Obsessive Compulsive Disorder ( OCD )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<criteria>sign patient inform consent ; primary obsessive compulsive disorder ; YBOCS score least 20 ; males/females 1865yrs ; treat adequate dose SSRI least 8 week stage illness ; currently use adequate , stable dose SSRI least 4 week respond . schizophrenia , psychotic disorder , bipolar I , current major depressive disorder ( HDRS ( 17 ) &gt; 18 , substance/alcohol dependence within last 6 month ; severe axis II ; suicidal score &gt; =6 MINI ; metallic implant cranium ; severe/unstable medical condition ; respond ECT TMS last 6 month ; history epilepsy ; neurological disorder lead increase intracranial pressure ; severe cardiac disorder/intracardiac line , pacemaker ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>